Concord Health Partners

What Concord Health Partners does

Concord Health Partners is a healthcare-focused private investment firm founded in 2017 and headquartered in Summit, New Jersey. The firm invests in companies with innovative technologies and solutions that advance healthcare through operational efficiencies, improved patient outcomes, and expanded access to care, across four stated verticals: Healthcare IT, Tech-Enabled Services, Healthcare Services, and Medical Technology. Its portfolio comprises 17 companies spanning patient engagement and financial technology (Cedar, Loyal), healthcare analytics (Clarify), care navigation (Thyme Care), clinical AI and revenue cycle (Smarter Technologies), behavioral health (NeuroFlow, Learn to Live), telehealth and remote monitoring (Iris Telehealth, Hicuity Health), healthcare IoT security (Cylera), AI-driven triage (Mednition), digital neurotherapeutics (MindMaze), workforce management (Flexwise), and medical devices (MIVI).

Concord's stated model is partnership-based: the firm works with management teams to build healthcare companies, providing capital alongside expertise, board leadership, and industry relationships drawn from a bench of senior advisors and an American Hospital Association (AHA) Special Advisor. The firm is founder-led (James T. Olsen as Founder & Managing Partner; Joseph Swedish as Partner Emeritus/co-founder; Benson Jose as COO/CFO), with an 11–50 employee footprint. Concord generates returns through equity investments in portfolio companies rather than selling products or services to end customers, and pricing/AUM/fund-size data is not publicly disclosed.

From a deal-activity standpoint, the firm participates as a co-investor in rounds across stages, including Cedar's $200 million Series D (Tiger Global-led, $3.2 billion valuation, January 2026). Portfolio companies have executed notable strategic moves in 2025–2026, including Smarter Technologies' acquisition of Pieces Technologies and launch of SmarterNotes, Clarify Health's acquisition of Loyal, and Thyme Care's inclusion in the 2026 CNBC Disruptor 50 list, signaling active value creation rather than passive capital deployment.

Name

Concord Health Partners

Legal name

Concord Health Partners

Website

https://concordhp.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Concord Health Partners is a healthcare-focused private investment firm founded in 2017 that provides capital and strategic support to companies across Healthcare IT, Tech-Enabled Services, Healthcare Services, and Medical Technology.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity / Venture Capital

NAICS

Business, Professional, Labor, Political, and Similar Organizations (8139)

SIC

Services-Health Services (8000)

akta.pro primary industry

Healthcare Licensing, Accreditation & Credentialing Boards (HLAJACAC)

akta.pro secondary industry

Hospitals, Clinics & Charitable Healthcare Providers (BPAGACAB)

Keywords

• Healthcare private equity
• Healthcare venture capital
• Healthcare technology investing
• Portfolio investments
• Growth capital healthcare

Headquarters

HQ city

Summit

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Investment Returns: Concord Health Partners generates returns through equity investments in healthcare companies, providing strategic capital and operational support to build leading healthcare businesses.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Concord Health Partners is a healthcare-focused private equity and venture capital investment firm that provides strategic capital, operational expertise, board leadership, and industry relationships to portfolio companies. The firm invests in healthcare IT, tech-enabled services, healthcare services, and medical technology companies, partnering with strong management teams to build leading healthcare businesses.

Product overview

Concord Health Partners is a healthcare-focused private equity and venture investment firm. It is not a product company but rather an investment platform that provides capital and strategic resources to healthcare technology and services companies. The firm partners with portfolio companies across four investment verticals: Healthcare IT, Tech-Enabled Services, Healthcare Services, and Medical Technology. The portfolio consists of 18 companies including Cedar (patient engagement/financial technology), Clarify (healthcare analytics), Mednition (AI triage), Smarter Technologies (clinical AI), Thyme Care (care navigation), NeuroFlow (behavioral health), Learn to Live (digital mental health), Loyal (patient engagement), and others spanning telehealth, remote monitoring, cybersecurity, workforce management, and digital therapeutics.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Private Equity and Venture Capital Investment Services

Named customers18 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and strategic.

• James T. OlsencoreOthersFounder and Managing Partner leading Concord Health Partners investment activities with extensive healthcare industry expertise.
• Joseph SwedishcoreOthersPartner Emeritus bringing deep healthcare industry knowledge and leadership experience to support investment strategy.
• Chris DeRienzo, MD, MPPstrategicOthersAHA Special Advisor providing clinical and policy expertise for healthcare investment evaluation and portfolio company support.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Welsh, Carson, Anderson & Stowe: Long-standing US healthcare-focused private equity firm with deep provider, services, and HCIT investing experience. Directly comparable to Concord as a specialist healthcare PE firm partnering with management teams to scale healthcare businesses.
• New Mountain Capital: Healthcare-dedicated private equity platform with multiple healthcare funds targeting tech-enabled services, healthcare IT, and payer/provider services. Closely matches Concord's healthcare-specialist PE/VC orientation and management-team partnership model.
• Oak HC/FT: Venture and growth equity firm exclusively focused on healthcare and financial services technology. Highly comparable to Concord's stage and sector focus, with portfolio overlap in patient engagement, value-based care, and digital health.
• Optum Ventures: Corporate venture arm of Optum/UHG investing across healthcare IT, services, and tech-enabled care delivery. Comparable as a healthcare-focused investor with strategic LP-style relationships and a bias toward operating synergies.
• Echo Health Ventures: Strategic venture partnership formed by Cambia Health Solutions and Mosaic Health Solutions to invest in healthcare innovation. Highly comparable to Concord as a healthcare-dedicated venture investor partnering with strategic health ecosystem players.

Broad incumbents

• Andreessen Horowitz (a16z Bio + Health): Large multi-stage venture firm with dedicated a16z Bio and Health funds investing in digital health, biotech, and care delivery. Comparable on healthcare venture activity (including co-investment in Cedar) but operates at much broader scale and stage range.
• Warburg Pincus (Healthcare): Global growth equity firm with a long-standing healthcare practice spanning services, HCIT, and life sciences. Comparable on healthcare PE investing but at significantly larger fund size and broader sector mandate.
• General Atlantic: Global growth equity investor with active healthcare and digital health practice. Comparable as a growth-stage healthcare investor but with broader geographic and sector footprint than Concord.
• KKR Health Care Strategic Growth: Alternative asset manager with dedicated healthcare strategic growth funds investing in tech-enabled services, healthcare IT, and provider/payer businesses. Comparable healthcare PE strategy at much larger firm scale.
• GV (Google Ventures): Venture arm of Alphabet with a strong life sciences and digital health practice. Comparable on healthcare venture investing and network-driven deal sourcing but with broader tech mandate and larger fund vehicles.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments25 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Concord Health Partners